Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT00147654 Completed - Clinical trials for Urinary Incontinence

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

Start date: November 2004
Phase: Phase 4
Study type: Interventional

The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).

NCT ID: NCT00143481 Completed - Clinical trials for Urinary Incontinence

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

Start date: March 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.

NCT ID: NCT00143377 Completed - Clinical trials for Urinary Incontinence

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Start date: September 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of Detrusitol (tolterodine tartrate) SR, 4 mg once daily, on patient's perception of the symptoms of overactive bladder and which of these bothersome symptoms are improved with treatment.

NCT ID: NCT00141128 Completed - Clinical trials for Urinary Incontinence, Stress

Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

Start date: December 2005
Phase: Phase 2
Study type: Interventional

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

NCT ID: NCT00139724 Completed - Clinical trials for Urinary Incontinence

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Start date: May 2005
Phase: Phase 3
Study type: Interventional

To evaluate efficacy of tolterodine extended release formulation compared with immediate release formulation in subjects with symptoms of overactive bladder

NCT ID: NCT00138749 Completed - Clinical trials for Urinary Incontinence, Stress

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Start date: November 2004
Phase: Phase 2
Study type: Interventional

A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.

NCT ID: NCT00137397 Completed - Clinical trials for Urinary Incontinence

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

Start date: November 2004
Phase: Phase 4
Study type: Interventional

The main aim of the study is to investigate whether taking Tolterodine for overactive bladder symptoms can reduce the thickness of the bladder wall, as measured by intra-vaginal ultrasound. This will help doctors to understand whether there is a link between changes in the thickness of the bladder wall and progression of symptoms.

NCT ID: NCT00127270 Completed - Clinical trials for Urinary Incontinence

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Start date: May 2005
Phase: Phase 4
Study type: Interventional

This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies.

NCT ID: NCT00125177 Completed - Clinical trials for Urinary Incontinence

IRIS: Incontinence Research Intervention Study

Start date: January 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The IRIS project stands for Incontinence Research Intervention Study. The purpose of this research project is to develop an effective behavioral therapy for urinary incontinence and specifically to test Knack therapy, a self-help treatment. The Knack therapy involves learning the skill of performing a pelvic muscle contraction simultaneously with an event known to trigger leakage, in order to stop that leakage.

NCT ID: NCT00124046 Completed - Clinical trials for Urinary Incontinence

Treatment of Persistent Urinary Incontinence in Children

Start date: September 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether surgical section of the filum terminale in children, when added to standard medical therapy, will result in a reliable and clinically-significant improvement in two main markers of incontinence within/at 12 months after treatment.